MX2009003129A - Derivados de oxadiazol con propiedades anti-inflamatorias e inmunosupresoras. - Google Patents

Derivados de oxadiazol con propiedades anti-inflamatorias e inmunosupresoras.

Info

Publication number
MX2009003129A
MX2009003129A MX2009003129A MX2009003129A MX2009003129A MX 2009003129 A MX2009003129 A MX 2009003129A MX 2009003129 A MX2009003129 A MX 2009003129A MX 2009003129 A MX2009003129 A MX 2009003129A MX 2009003129 A MX2009003129 A MX 2009003129A
Authority
MX
Mexico
Prior art keywords
inflammatory
oxadiazole derivatives
immunosuppressive properties
immunosuppressive
properties
Prior art date
Application number
MX2009003129A
Other languages
English (en)
Inventor
Sven Weiler
Frederic Zecri
Rainer Albert
Nigel Graham Cooke
Ian Lewis
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MX2009003129A publication Critical patent/MX2009003129A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4245—Oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Abstract

Se dan a conocer compuestos policíclicos de la siguiente fórmula I: (ver fórmula (I)) y su uso como agentes anti-inflamatorios e inmunosupresores.
MX2009003129A 2006-09-29 2007-09-27 Derivados de oxadiazol con propiedades anti-inflamatorias e inmunosupresoras. MX2009003129A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06121495 2006-09-29
PCT/EP2007/008431 WO2008037476A1 (en) 2006-09-29 2007-09-27 Oxadiazole derivatives with anti-inflammatory and immunosuppressive properties

Publications (1)

Publication Number Publication Date
MX2009003129A true MX2009003129A (es) 2009-04-06

Family

ID=37771076

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009003129A MX2009003129A (es) 2006-09-29 2007-09-27 Derivados de oxadiazol con propiedades anti-inflamatorias e inmunosupresoras.

Country Status (11)

Country Link
US (1) US20100087491A1 (es)
EP (1) EP2081916A1 (es)
JP (1) JP2010504932A (es)
KR (1) KR20090057070A (es)
CN (1) CN101522646A (es)
AU (1) AU2007302262A1 (es)
BR (1) BRPI0717656A2 (es)
CA (1) CA2664268A1 (es)
MX (1) MX2009003129A (es)
RU (1) RU2009115963A (es)
WO (1) WO2008037476A1 (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007292993B2 (en) 2006-09-07 2013-01-24 Idorsia Pharmaceuticals Ltd Pyridin-4-yl derivatives as immunomodulating agents
CA2661315C (en) 2006-09-08 2015-11-24 Actelion Pharmaceuticals Ltd Pyridin-3-yl derivatives as immunomodulating agents
RU2442780C2 (ru) 2006-09-21 2012-02-20 Актелион Фармасьютиклз Лтд Фенильные производные и их применение в качестве иммуномодуляторов
AU2007334436A1 (en) 2006-12-15 2008-06-26 Abbott Laboratories Novel oxadiazole compounds
DK2125797T3 (da) 2007-03-16 2014-02-10 Actelion Pharmaceuticals Ltd Aminopyridinderivater som s1p1/edg1-receptoragonister
AU2008306885B2 (en) 2007-10-04 2013-12-05 Merck Serono S.A. Oxadiazole derivatives
CA2696829C (en) 2007-10-04 2017-07-04 Merck Serono S.A. Oxadiazole diaryl compounds
SI2252609T1 (sl) * 2008-03-07 2013-07-31 Actelion Pharmaceuticals Ltd. Derivati piridin-2-ila kot imunomodulacijska sredstva
US8410151B2 (en) * 2008-03-07 2013-04-02 Actelion Pharmaceuticals Ltd Aminomethyl benzene derivatives
NZ589617A (en) 2008-05-14 2012-06-29 Scripps Research Inst 3-(Inden-4-yl)-5-(phenyl)-1,2,4-oxadiazole and 3-(tetralin-5-yl)-5-(phenyl)-1,2,4-oxadiazole derivatives
EP2241558A1 (en) * 2009-04-03 2010-10-20 Merck Serono SA Oxadiazole derivatives
TWI410421B (zh) 2009-07-16 2013-10-01 Actelion Pharmaceuticals Ltd 吡啶－４－基衍生物
US8399451B2 (en) 2009-08-07 2013-03-19 Bristol-Myers Squibb Company Heterocyclic compounds
WO2011056916A1 (en) * 2009-11-05 2011-05-12 Lexicon Pharmaceuticals, Inc. Tryptophan hydroxylase inhibitors for the treatment of cancer
EP2560969B1 (en) 2010-04-23 2015-08-12 Bristol-Myers Squibb Company 4-(5-isoxazolyl or 5-pyrrazolyl-1,2,4-oxadiazol-3-yl)-mandelic acid amides as sphingosin-1-phosphate 1 receptor agonists
WO2011136927A1 (en) 2010-04-27 2011-11-03 Allergan, Inc. 3-(4-((1h-imidazol-1-yl)methyl)phenyl)-5-aryl-1,2,4-oxadiazole derivatives as sphingosine-1 phosphate receptors modulators
TW201206429A (en) * 2010-07-08 2012-02-16 Merck Serono Sa Substituted oxadiazole derivatives
ES2548258T3 (es) 2010-09-24 2015-10-15 Bristol-Myers Squibb Company Compuestos de oxadiazol sustituidos y su uso como agonistas de S1P1
KR101317492B1 (ko) * 2010-09-29 2013-10-15 가톨릭대학교 산학협력단 Ａｇ490을 유효성분으로 포함하는 면역질환의 예방 또는 치료용 조성물
AU2012208325B2 (en) 2011-01-19 2016-12-22 Idorsia Pharmaceuticals Ltd 2-methoxy-pyridin-4-yl derivatives
CN114573574A (zh) 2015-05-20 2022-06-03 爱杜西亚药品有限公司 一种化合物的结晶形式
CA3038106A1 (en) 2016-09-29 2018-04-05 Celgene International Ii Sarl Compounds and methods for treating lupus
US10676467B2 (en) * 2017-06-30 2020-06-09 Washington University Compositions for binding sphingosine-1-phosphate receptor 1 (S1P1), imaging of S1P1, and methods of use thereof
CN107827837B (zh) * 2017-11-21 2021-09-24 苏州朗科生物技术股份有限公司 鞘氨醇-1-磷酸受体调节剂化合物及其制备方法与应用
WO2022149925A1 (ko) * 2021-01-08 2022-07-14 광주과학기술원 신규한 트립토판 수산화효소 저해제 및 이의 용도

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU765203B2 (en) * 1999-04-19 2003-09-11 Shionogi & Co., Ltd. Sulfonamide derivatives having oxadiazole rings
JP4219810B2 (ja) * 2001-10-26 2009-02-04 塩野義製薬株式会社 Ｍｍｐ阻害作用を有するスルホンアミド誘導体
CA2488117A1 (en) * 2002-06-17 2003-12-24 Merck & Co., Inc. 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)pyrrolidine-3-carboxylates as edg receptor agonists
CN1859908A (zh) * 2003-10-01 2006-11-08 默克公司 作为s1p受体激动剂的3,5－芳基、杂芳基或环烷基取代的－1,2,4－噁二唑类化合物
EP1760071A4 (en) * 2004-06-23 2008-03-05 Ono Pharmaceutical Co COMPOUND WITH S1P RECEPTOR BINDING ABILITY AND USE THEREOF
WO2006047195A2 (en) * 2004-10-22 2006-05-04 Merck & Co., Inc. 2-(aryl)azacyclylmethyl carboxylates, sulfonates, phosphonates, phosphinates and heterocycles as s1p receptor agonists
PL1826197T3 (pl) * 2004-12-13 2012-06-29 Ono Pharmaceutical Co Pochodna kwasu aminokarboksylowego i jej zastosowanie lecznicze
AU2006256968A1 (en) * 2005-06-08 2006-12-14 Novartis Ag Polycyclic oxadiazoles or I soxazoles and their use as SIP receptor ligands
CN101282936B (zh) * 2005-10-07 2012-05-16 橘生药品工业株式会社 氮化杂环化合物及包含其的药物组合物
JP2009269819A (ja) * 2006-08-25 2009-11-19 Asahi Kasei Pharma Kk アミン化合物

Also Published As

Publication number Publication date
RU2009115963A (ru) 2010-11-10
CN101522646A (zh) 2009-09-02
BRPI0717656A2 (pt) 2014-04-29
JP2010504932A (ja) 2010-02-18
US20100087491A1 (en) 2010-04-08
AU2007302262A1 (en) 2008-04-03
EP2081916A1 (en) 2009-07-29
KR20090057070A (ko) 2009-06-03
WO2008037476A1 (en) 2008-04-03
CA2664268A1 (en) 2008-04-03

Similar Documents

Publication Publication Date Title
MX2009003129A (es) Derivados de oxadiazol con propiedades anti-inflamatorias e inmunosupresoras.
MX2009008798A (es) Derivados de iminipiridina y sus usos como microbicidas.
ZA200807274B (en) Novel pyridine derivatives
TW200612958A (en) Substituted imidazole derivatives
ECSP10010722A (es) Compuestos orgánicos
MX342683B (es) Analogos de ciclopamina.
MY153921A (en) Aminopyrazole derivatives
MX2007004699A (es) Derivados de indol y bencimidazol.
CL2012000707A1 (es) Compuestos derivados de [5-(pirrolo[1,2-c][1.2.3]triazin-7-il)tetrahidrofuran-2-il]metanol; composición farmacéutica; y su uso para el tratamiento de la hepatitis c.
PH12012501905A1 (en) Quinoline derivatives and their use as fungicides
TW200708511A (en) Novel thiophene derivatives
TW200716552A (en) Novel thiophene derivatives
WO2007115821A3 (en) Organic compounds
MX2010005889A (es) Derivados de tiofeno como agonistas de s1p1/edg1.
MX2010004576A (es) Derivados de pirimidina novedosos.
TN2010000101A1 (en) Fungicidal 2-alkylthio-2-quinolinyloxy -acetamide derivatives
RS51646B (en) TRICYCLIC UNITS AND THEIR USE AS MODULATORS OF GLUCOCORTICOID RECEPTORS
TW200833324A (en) Sulfonamide derivatives
ATE554066T1 (de) Entzündungshemmende substituierte cyclobutendionverbindungen
HK1142608A1 (en) 5-pyridinone substituted indazoles and pharmaceutical compositions thereof 5-
TW200700358A (en) Organic compounds
MX2009005071A (es) Compuestos de pirazol y triazol sustituidos como inhibidores de ksp.
MX2007011493A (es) Modalidades antiinflamatorias.
SG158091A1 (en) Imidazoazepinone compounds
MX2009013515A (es) Derivados de 7-alquinil-1,8-naftiridonas, su preparacion y su aplicacion en terapeutica.

Legal Events

Date Code Title Description
HH Correction or change in general
FA Abandonment or withdrawal